Skip to content

Analysis of Postoperative Clinical Efficacy and Visual Quality of VisuMax 800 Femtosecond System SMILEpro

Analysis of Postoperative Clinical Efficacy and Visual Quality of VisuMax 800 Femtosecond System SMILEpro

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121848
Enrollment
Unknown
Registered
2026-04-03
Start date
2026-04-04
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Error

Interventions

Experimental group:None

Sponsors

Hainan Optometry and Ophthalmology Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Myopia and myopic astigmatism patients eligible for SMILEpro surgery using VisuMax 800 femtosecond system

Exclusion criteria

Exclusion criteria: 1. Patients with severe eye diseases (including severe dry eye, keratoconus, uncontrolled glaucoma, uncontrolled cataracts, severe corneal diseases, etc.) 2. Systemic connective tissue diseases and autoimmune diseases 3. Serious mental illness 4. Pregnant and lactating women 5. Thin corneal thickness 6. Excessive pupil diameter 7. Unstable refractive power 8. Age under 18 years old 9. High expectations for surgery

Design outcomes

Primary

MeasureTime frame
naked eye vision;Best corrected visual acuity;

Secondary

MeasureTime frame
diopter;Corneal topography map;Corneal biomechanical parameters;Contrast sensitivity;higher-order aberrations;scattered light;Patient Visual Quality Questionnaire Survey;

Countries

China

Contacts

Public ContactChenWei

Wenzhou Medical University Affiliated Eye and Vision Hospital

chenweimd@wmu.edu.cn+86 137 5772 8118

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026